The Federal Trade Commission and seven state attorneys general want a federal judge to find Martin Shkreli in contempt.
A federal judge is being asked to hold the ex-con in contempt and force him to surrender his trading profits and any pharmaceutical stocks he owns.
NEW YORK, Oct 13 (Reuters) - Martin Shkreli has violated a lifetime ban from the pharmaceutical industry by trading stocks and discussing his opinions about companies in the industry, federal ...
The Federal Trade Commission has asked a federal judge to hold Martin Shkreli, the former pharmaceutical executive better known as “Pharma Bro” in the 2010s, in contempt of court for allegedly ...
The Federal Trade Commission (FTC) and a coalition of seven states asked a federal court on Tuesday to punish Martin Shkreli for “flagrantly and repeatedly” violating a lifetime ban from being ...
In this Aug. 3, 2017, file photo, Martin Shkreli, former chief executive officer of Turing Pharmaceuticals AG, arrives at federal court in Brooklyn, New York. automation Martin Shkreli's lifetime ban ...
Martin Shkreli’s 2022 release conditions bar him from participating in the pharmaceutical industry, including ownership stakes or business decisions ...
The Federal Trade Commission and seven states asked a federal judge on Tuesday to hold notorious "Pharma bro" Martin Shkreli in contempt. The FTC and the states allege that Shkreli "flagrantly and ...
The Federal Trade Commission said Martin Shkreli is still trading pharmaceutical stocks. The FTC said the "Pharma Bro" continues to do this despite a lifetime ban. In a court filing, the FTC and seven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results